Copyright
©The Author(s) 2018.
World J Gastroenterol. Feb 14, 2018; 24(6): 657-670
Published online Feb 14, 2018. doi: 10.3748/wjg.v24.i6.657
Published online Feb 14, 2018. doi: 10.3748/wjg.v24.i6.657
Figure 3 Relative mRNA expression (2(-∆CT) × 1000) of PTPN2, PTPN22 and IFN-γ.
Relative mRNA expression of PTPN2 (A) and PTPN22 (B) in CD and healthy control subjects. Relative mRNA expression of IFN-γ was correlated with CD and healthy control subjects with either PTPN2:rs478582 (C) or PTPN22:2476601 (D). IFN-γ: Interferon-γ; CD: Crohn’s disease; PTPN2: Protein tyrosine phosphatase non-receptor type 2; PTPN22: Protein tyrosine phosphatase non-receptor type 22. aP < 0.05.
- Citation: Sharp RC, Beg SA, Naser SA. Role of PTPN2/22 polymorphisms in pathophysiology of Crohn’s disease. World J Gastroenterol 2018; 24(6): 657-670
- URL: https://www.wjgnet.com/1007-9327/full/v24/i6/657.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i6.657